The presentation focuses on Algosource and its integrated approach to the entire value chain of microalgae products, emphasizing nutraceuticals and high-value applications. It discusses the challenges associated with developing nutraceutical products and outlines the innovation process for functional product development. Additionally, the presentation highlights Spirulysat and its double-blind clinical study against a placebo, demonstrating its efficacy and potential in the nutraceutical market.
